Anti-Spike RBD Antibody (R14-F8) is a monoclonal antibody that is specificly targeting for the spike receptor binding domain of SARS-CoV-2, recognizing both Wuhan-Hu-1 and the Indian (Delta) variant. MW :150 KD.